387 related articles for article (PubMed ID: 32735190)
1. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.
Ansari B; Tote KM; Rosenberg ES; Martin EG
Public Health Rep; 2020; 135(1_suppl):100S-127S. PubMed ID: 32735190
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
3. The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.
Mauri AI; Townsend TN; Haffajee RL
Milbank Q; 2020 Mar; 98(1):57-105. PubMed ID: 31800142
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
[TBL] [Abstract][Full Text] [Related]
5. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
[TBL] [Abstract][Full Text] [Related]
6. The US Opioid Crisis: Current Federal and State Legal Issues.
Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
[TBL] [Abstract][Full Text] [Related]
7. Evidence for state, community and systems-level prevention strategies to address the opioid crisis.
Haegerich TM; Jones CM; Cote PO; Robinson A; Ross L
Drug Alcohol Depend; 2019 Nov; 204():107563. PubMed ID: 31585357
[TBL] [Abstract][Full Text] [Related]
8. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
Strike C; Watson TM
Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
[TBL] [Abstract][Full Text] [Related]
9. The use of cannabis in response to the opioid crisis: A review of the literature.
Vyas MB; LeBaron VT; Gilson AM
Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
[TBL] [Abstract][Full Text] [Related]
10. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
11. Provider perceptions of system-level opioid prescribing and addiction treatment policies.
Haffajee RL; French CA
Curr Opin Psychol; 2019 Dec; 30():65-73. PubMed ID: 30856591
[TBL] [Abstract][Full Text] [Related]
12. State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review.
Beaudoin FL; Banerjee GN; Mello MJ
J Opioid Manag; 2016; 12(2):109-18. PubMed ID: 27194195
[TBL] [Abstract][Full Text] [Related]
13. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
[TBL] [Abstract][Full Text] [Related]
14. In our war against the opioid epidemic, could 'weed' be a winner?
Ding DD; Balkrishnan R; Diaby V
Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):423-429. PubMed ID: 32799573
[TBL] [Abstract][Full Text] [Related]
15. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
16. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
[TBL] [Abstract][Full Text] [Related]
17. The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons.
Liang D; Shi Y
Drug Alcohol Depend; 2020 Jan; 206():107754. PubMed ID: 31786399
[TBL] [Abstract][Full Text] [Related]
18. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
[TBL] [Abstract][Full Text] [Related]
19. Combating Opioid Overdose With Public Access to Naloxone.
Mitchell KD; Higgins LJ
J Addict Nurs; 2016; 27(3):160-79. PubMed ID: 27580190
[TBL] [Abstract][Full Text] [Related]
20. Drivers, Beliefs, and Barriers Surrounding Surgical Opioid Prescribing: A Qualitative Study of Surgeons' Opioid Prescribing Habits.
Sceats LA; Ayakta N; Merrell SB; Kin C
J Surg Res; 2020 Mar; 247():86-94. PubMed ID: 31767277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
